# Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

> **NCT04774822** · — · COMPLETED · sponsor: **RETINA-AI Health, Inc.** · enrollment: 397 (actual)

## Conditions studied

- Diabetic Retinopathy
- Diabetic Eye Problems
- Diabetic Macular Edema

## Interventions

- **PROCEDURE:** Color Fundus Photography
- **DRUG:** Mydriatics Agent
- **PROCEDURE:** Optical Coherence Tomography (OCT)

## Key facts

- **NCT ID:** NCT04774822
- **Lead sponsor:** RETINA-AI Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-25
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-08-31
- **Target enrollment:** 397 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774822, "Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04774822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*